Large gap with delayed quotes
|
Last quote
08/29/2025
-
18:00:00
|
Bid
08/29/2025 -
17:29:57
|
Bid Volume |
Ask
08/29/2025 -
17:29:57
|
Ask Volume |
|---|---|---|---|---|
|
264.50
-1.00
(
-0.38% )
|
265.00
|
4 |
265.50
|
3,181 |
Analysis date: 29.08.2025
Global Evaluation
Positive
Positive
The stock is classified in the positive zone since 19.08.2025.
Interest
Strong
Strong
Three stars since 26.08.2025.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 25.07.2025 at a price of 285.50.
Evaluation
Undervalued
Undervalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately undervalued.
MT Tech Trend
Neutral
Neutral
The stock is currently trading close to its dividend-adjusted forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this, the stock traded above its moving average since 15.04.2025.
4wk Rel Perf
-5.12%
-5.12%
The four-week dividend-adjusted underperformance versus STOXX600 is 5.12%.
Sensibility
Low
Low
Low, no change over 1 year.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.75%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.06%.
Mkt Cap in $bn
4.21
4.21
With a market capitalization between $2 & $8bn, MEDICOVER is considered a mid-cap stock.
G/PE Ratio
2.60
2.60
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
16.72
16.72
The estimated PE is for the year 2028.
LT Growth
42.65%
42.65%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
5
5
Over the last seven weeks, an average of 5 analysts provided earnings per share estimates.
Dividend Yield
0.83%
0.83%
The twelve month estimated dividend yield represents 13.89% of earnings forecasts.
Beta
64
64
For 1% of index variation, the stock varies on average by 0.64%.
Correlation
0.33
0.33
Stock movements are strongly independent of index variations.
Value at Risk
21.83
21.83
The value at risk is estimated at SEK 21.83. The risk is therefore 8.25%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.07.2024
02.07.2024